Atea Pharmaceuticals Cash Flow Statement (2020-2022) | AVIR

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022
Operating Activities
Net Income -3.99M-17.62M20.66M30.71M1.54M-28.19M117.13M-42.08M-31.34M-8.07M-34.43M
Share-based Compensation 0.19M0.21M4.24M2.82M7.27M10.01M10.99M11.35M11.66M11.91M11.50M11.64M
Gains from Sales and Divestitures 0.02M
Gains from Investment Securities 0.29M3.41M2.21M3.23M3.44M10.52M2.90M
Non-cash Items 22.41M277.89M31.24M
Cash from Operations -4.51M-7.80M-9.48M318.52M-16.84M-17.35M22.60M-75.42M-59.01M-19.19M-21.24M-21.55M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 7.93M
Depreciation & Amortization (CF) 0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.04M0.11M0.10M
Change in Working Capital
Change in Account Payables -0.15M2.79M1.05M-4.18M3.73M12.72M11.49M-17.66M-0.88M10.23M-12.77M1.43M
Change in Accured Expenses -0.37M1.41M3.22M8.18M6.63M16.96M9.69M10.60M-28.01M-13.57M2.48M1.49M
Investing Activities
Capital Expenditures 0.01M0.01M0.70M1.22M0.02M
Change in Acquisitions & Divestments 91.89M
Cash from Investing Activities -0.01M-0.01M-0.04M-1.88M-486.98M33.49M
Financing Activities
Other financing activities 0.91M
Change in Capital Stock
Shares Issued 317.58M0.47M0.06M0.80M0.14M0.22M0.14M
Preferred Shares Issued 107.48M
Misc.
Cash from Financing Activities -0.01M106.45M-0.91M426.22M0.47M0.06M0.80M0.14M0.22M0.15M
Change in Cash -4.51M98.64M-10.41M744.73M-16.37M-17.29M23.40M-75.28M-58.83M-21.07M-508.07M11.94M
Beginning Cash Balance 21.66M17.15M115.79M105.38M850.12M833.75M816.26M839.66M764.38M705.54M684.48M-11.94M
Free Cash Flow -4.51M-7.80M-9.50M318.52M-16.84M-17.35M22.60M-75.42M-59.71M-20.41M-21.26M-21.55M
Net Cash Flow -4.51M98.65M-10.41M744.73M-16.37M-17.29M23.40M-75.28M-58.83M-21.07M-508.07M11.94M